CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parallel Bio, a biotech company pioneering human-first drug discovery, today announced it has raised $21 million Series A funding, led by AIX Ventures. The round ...
Abstract: The virtual-to-real paradigm, i.e., training models on virtual data and then applying them to solve real-world problems, has attracted more and more attention from various domains by ...
BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (Nasdaq: SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that it received a notification ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results